Atlas Venture
Atlas Venture creates and invests in biotech startup companies with seed and early stage venture investments.
Business Model: B2B
Revenue: $35M
Employees: 201-500
Rankings
Detailed Atlas Venture Information
Geographic Data
Address: 25 1st St
City: Cambridge
State: MA
Zip: 02141
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$3B
Social
Facebook
Twitter
Linkedin
Crunchbase
Metrics
2,189,027Website Global Rank
8,867Website Monthly Traffic
Twitter Followers
Description
Atlas Venture is an early-stage venture capital firm that creates and invests in biotech startup companies led by promising entrepreneurs focusing on life sciences innovation. Its seed-led venture creation strategy rigorously selects and focuses investment on the most compelling opportunities to build scalable businesses and realize value.
Contact Phone:
+16175882600
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 2/2000 | Sedona Networks | Series B | 22M |
| 5/2012 | Mojomotors | Series A | 3M |
| 9/2001 | Get Connected Inc | Series C | 0 |
| 6/2011 | Nimbus Therapeutics | Series A | 24M |
| 3/2013 | Preact | Seed Round | 750k |
| 7/2003 | Starbak | Series B | 3M |
| 9/2014 | Kinvey | Series B | 10.9M |
| 1/1999 | Vividon, Inc | Series A | - |
| 4/2007 | ExtendMedia | Series B | 12M |
| 10/2003 | Arrow Therapeutics | Series B | 34.9M |
| 1/2005 | Get Connected Inc | Series D | 0 |
| 1/2005 | CLK Design Automation | Series A | 5M |
| 7/2013 | Harbour Antibodies | Series A | 3.3M |
| 1/2007 | Novexel | Series B | 65M |
| 8/2015 | JenaValve Technology | Series C | 26.5M |
| 7/2013 | JenaValve Technology | Series C | 62.5M |
| 6/2010 | JenaValve Technology | Series B | 22.7M |
| 4/2002 | Newron Pharmaceuticals | Venture Round | 22M |
| 6/2013 | InsightSquared | Series B | 8M |
| 4/2014 | JenaValve Technology | Series C | 0 |
| 2/2013 | Timbre | Seed Round | 360k |
| 8/2014 | Ready4 | Series A | 3M |
| 11/2001 | Bang Networks | Series B | 14M |
| 1/2007 | Proprius Pharmaceuticals | Series A | 0 |
| 11/2016 | Magenta Therapeutics | Series A | 48.5M |
| 1/2019 | Remix Therapeutics | Seed Round | 16M |
| 8/1999 | Quantum Bridge Communications | Series B | 16M |
| 6/1999 | Salu Inc | Series A | 5M |
| 7/2001 | Trebia Networks | Venture Round | 0 |
| 7/2000 | Musicbank | Venture Round | 20M |
| 7/2014 | Button | Seed Round | 2.3M |
| 7/2014 | FreshBooks | Series A | 30M |
| 3/2002 | Signature BioScience | Series E | 0 |
| 1/2010 | Spero Therapeutics | Seed Round | - |
| 1/2014 | Drizly | Seed Round | 0 |
| 5/2018 | Plastiq | Series B | 16M |
| 7/2012 | Mortar Data | Seed Round | 1.8M |
| 2/2013 | Plastiq | Series A | 6M |
| 7/2014 | FORTIFIED Bicycle | Venture Round | 800k |
| 9/2012 | Lilliputian Systems | Venture Round | 0 |
| 11/2003 | Percardia | Series D | 23.5M |
| 12/2014 | Appcito | Series A | 0 |
| 6/2011 | GrabCAD | Seed Round | 1.1M |
| 9/2017 | Disarm Therapeutics | Series A | 30M |
| 1/2011 | MileWise | Seed Round | 1.5M |
| 4/1999 | Spotfire | Series B | 6M |
| 4/2000 | Quantum Bridge Communications | Series C | 0 |
| 6/2019 | Vedere Bio ll | Series A | 21M |
| 4/2006 | MOO.COM | Series A | 5M |
| 3/2001 | CellZome | Series B | 0 |
| 6/2018 | Akero Therapeutics | Series A | 65M |
| 6/2006 | Carbon Black | Series B | 9.8M |
| 8/2002 | Archemix | Series A | 51.8M |
| 3/2003 | CellZome | Series C | 32M |
| 12/2014 | Appcues | Seed Round | 1.2M |
| 2/2010 | Veracode | Series D | 12.3M |
| 3/2007 | Azea Networks | Series D | 6M |
| 2/2002 | E Ink | Venture Round | 15M |
| 9/2017 | Replimune Group | Series B | 55M |
| 5/2014 | Allclasses | Seed Round | 1.5M |
| 5/2012 | Egalet | Series B | 14.3M |
| 1/2018 | Quench Bio | Seed Round | - |
| 7/2003 | Alnylam Pharmaceuticals | Private Equity Round | 24.6M |
| 12/2009 | On-Q-ity | Series A | 26M |
| 11/2013 | DraftKings | Series B | 24M |
| 10/2000 | ELabsEurope | Series B | 0 |
| 2/2021 | Xilio Therapeutics | Series C | 95M |
| 6/2010 | picoChip | Venture Round | 20M |
| 2/2016 | Spero Therapeutics | Series B | 30M |
| 11/2015 | Viridian Therapeutics | Series C | 0 |
| 5/2020 | HotSpot Therapeutics | Series B | 65M |
| 5/2022 | Remix Therapeutics | Series B | 0 |
| 11/2011 | Objective Logistics | Venture Round | 1.5M |
| 10/2008 | Inspirational Stores | Series B | 10M |
| 10/2007 | OwnerIQ | Series A | 2M |
| 9/2022 | Pheon Therapeutics | Series A | 0 |
| 3/2009 | Veracode | Series C | 5M |
| 2/2013 | dataxu | Series D | 27M |
| 1/2021 | Ikena Oncology | Series B | 0 |
| 1/2019 | Third Harmonic Bio | Series A | 50M |
| 4/2016 | Gemini Therapeutics | Seed Round | 2M |
| 7/2006 | DisplayLink | Series B | 13.3M |
| 10/2019 | Disc Medicine | Series A | 50M |
| 8/2021 | Vigil Neuroscience | Series B | 0 |
| 8/2006 | Netonomy | Series F | 3.7M |
| 12/2020 | Remix Therapeutics | Series A | 65M |
| 2/2021 | Gemini Therapeutics | Post-IPO Equity | 0 |
| 8/2006 | Dailymotion | Series A | 9.5M |
| 10/2020 | Q32 Bio | Series B | 60M |
| 5/2020 | Q32 Bio | Series A | 46M |
| 7/2021 | Nimbus Therapeutics | Private Equity Round | 105M |
| 7/2010 | LearnBoost | Angel Round | 975k |
| 6/2015 | Spero Therapeutics | Series A | 0 |
| 1/2004 | Marathon Technologies | Venture Round | 8.8M |
| 4/2007 | Egalet | Series B | 27.6M |
| 12/2013 | Spero Therapeutics | Seed Round | - |
| 1/2012 | Translate Bio | Series A | 20.7M |
| 4/2006 | Valore | Series A | 4.4M |
| 9/2013 | DataRobot | Seed Round | 3.3M |
| 2/2014 | Carbon Black | Series E | 38.3M |
| 12/2008 | ExtendMedia | Venture Round | 10M |
| 9/2015 | Skillz | Series B | 15.1M |
| 7/2000 | SpotLife | Series C | 0 |
| 12/2000 | SpotLife | Series C | 0 |
| 8/2001 | NaviNet | Series C | 0 |
| 4/2014 | Spero Therapeutics | Series A | 0 |
| 10/2009 | Dailymotion | Series C | 0 |
| 10/2020 | Be Biopharma | Series A | 52M |
| 9/2015 | Intellia Therapeutics | Series B | 0 |
| 12/2018 | Akero Therapeutics | Series B | 70M |
| 10/2005 | Kalido | Series C | 13.5M |
| 11/2020 | Kinaset Therapeutics | Series A | 40M |
| 3/2000 | Fireclick | Series B | 11M |
| 11/2018 | Cadent Therapeutics | Series B | 40M |
| 6/2001 | Wavesmith Networks | Series B | 31M |
| 11/2005 | Active Endpoints | Series B | 6M |
| 8/2000 | Vasca | Venture Round | 13.2M |
| 9/2022 | Nimbus Therapeutics | Venture Round | 0 |
| 1/2009 | Zoopla | Series A | 5.5M |
| 8/2008 | Xelerated | Series E | 0 |
| 1/2006 | Xytis | Series B | 24.5M |
| 1/2010 | Molecular Biometrics | Series B | 12.5M |
| 5/2007 | Xelerated | Series D | 0 |
| 11/2003 | Neurotech | Venture Round | 14.1M |
| 1/2015 | Surface Oncology | Series A | 35M |
| 7/2018 | HotSpot Therapeutics | Series A | 45M |
| 6/2000 | Moreover.com | Series A | 21M |
| 11/2006 | Neurotech | Series B | 0 |
| 10/2013 | Par8o | Seed Round | - |
| 4/2019 | Dyne Therapeutics | Series A | 50M |
| 8/2012 | Hopper | Series B | 12M |
| 6/2023 | K36 Therapeutics | Series B | 0 |
| 9/2012 | Annovation BioPharma | Series A | 8M |
| 8/2014 | Vurb | Series A | 8M |
| 3/2004 | Phylogix Inc. | Series B | 12M |
| 5/2014 | Vhoto | Seed Round | 750k |
| 8/2013 | Patreon | Seed Round | 2.1M |
| 3/2006 | ARCA biopharma | Series A | 15M |
| 12/2019 | IFM Therapeutics | Venture Round | 55.5M |
| 9/2009 | Helicos BioSciences | Post-IPO Equity | 10M |
| 12/2010 | Zoopla | Series B | 5M |
| 6/2001 | Supplyworks | Series B | 19.2M |
| 7/2011 | Larimar Therapeutics | Series C | 33M |
| 9/2006 | Liquid Machines | Series C | 7.5M |
| 10/2007 | Bluespec | Series C | 4.3M |
| 2/2018 | Avrobio | Series B | 60M |
| 12/2004 | Prestwick Pharmaceuticals | Series B | 37M |
| 4/2013 | Gizmox | Series B | 0 |
| 7/2004 | Icera | Series B | 22.5M |
| 3/2003 | Livevault | Series B | 10M |
| 4/2004 | Dynogen Pharmaceuticals | Series B | 0 |
| 9/2004 | Ellacoya Networks | Venture Round | 7M |
| 7/2009 | Avila Therapeutics | Series B | 30M |
| 11/2005 | Lilliputian Systems | Series B | 30M |
| 2/2014 | FlashNotes | Series A | 3.6M |
| 8/2005 | Aureon Laboratories | Series B | 20M |
| 9/2001 | ThreeFive Photonics | Series A | 6.5M |
| 4/2015 | ZappRx | Series A | 14M |
| 9/2013 | Snapguide | Series A | 3M |
| 8/2011 | Kinvey | Seed Round | 2M |
| 10/2011 | Secret Escapes | Series A | - |
| 11/2014 | Intellia Therapeutics | Series A | 0 |
| 4/2009 | dataxu | Series A | 6M |
| 5/2013 | DraftKings | Series A | 9.8M |
| 1/2014 | Integral Ad Science | Series D | 30M |
| 2/2015 | Lysosomal Therapeutics | Series A | 20M |
| 8/2016 | Avrobio | Series A | 25M |
| 10/2000 | Vividon, Inc | Series B | 15M |
| 1/2018 | Generation Bio | Series A | 25M |
| 7/2014 | Vidado | Series B | 10M |
| 7/2013 | Privy | Seed Round | 1.7M |
| 4/2013 | Vidado | Series A | 2.4M |
| 7/2007 | NovaMed Pharmaceuticals | Series A | 5M |
| 11/2001 | Revit Technology Corporation | Venture Round | 16.1M |
| 9/2017 | Rodin Therapeutics | Series C | 0 |
| 4/2012 | Viridian Therapeutics | Series B | 20M |
| 3/2007 | Nitec Pharma AG | Series B | 26M |
| 6/2009 | Keas | Series A | 11M |
| 5/2012 | LuckyLabs | Series A | 3.5M |
| 2/2000 | Viquity | Series B | 7.8M |
| 4/2011 | F-Star Therapeutics | Venture Round | 0 |
| 6/2009 | Seatwave | Series D | 17M |
| 10/2003 | picoChip | Series B | 17M |
| 11/2006 | Scali | Venture Round | 3.5M |
| 1/2000 | Obongo | Series B | 20M |
| 6/2014 | Numerate | Series C | 8.2M |
| 11/2012 | Spindle | Venture Round | 2.3M |
| 12/2004 | Orthogon Systems | Venture Round | 8M |
| 6/2013 | Keas | Series B | 8M |
| 12/2009 | Pixtronix | Venture Round | 0 |
| 11/2014 | InsightSquared | Series C | 13.5M |
| 9/2007 | F-Star Therapeutics | Series A | 8.3M |
| 11/2003 | Apogee Photonics | Series C | 7.5M |
| 3/2010 | Aureon Laboratories | Series C | - |
| 5/2000 | Salu Inc | Series B | 28.5M |
| 2/2001 | Vividon, Inc | Series B | 5M |
| 3/2014 | Ataxion | Series A | 17M |
| 8/2021 | Versanis Bio | Series A | 0 |
| 4/2007 | Ellacoya Networks | Series E | 13M |
| 1/1998 | Develogen AG | Series A | 3M |
| 3/2001 | eMusicLive | Series B | 3.5M |
| 7/2005 | ShoZu | Series B | 12M |
| 4/2010 | Nimbus Therapeutics | Seed Round | 3.5M |
| 3/2000 | GoCargo | Series B | 13.3M |
| 7/2005 | Apogee Photonics | Venture Round | 9.7M |
| 9/2015 | Replimune Group | Series A | 30M |
| 6/2000 | GoIndustry.com | Venture Round | 39.1M |
| 3/2011 | Nimbus Therapeutics | Seed Round | 1.5M |
| 11/2012 | Fancred | Debt Financing | 500k |
| 10/2004 | Workhuman | Series B | 9.3M |
| 9/2013 | ZappRx | Seed Round | 0 |
| 5/2009 | Kalido | Series E | 5.1M |
| 3/2006 | InfaCare Pharmaceutical | Series A | 30M |
| 12/2006 | Songbird | Series A | 8M |
| 8/2004 | Active Endpoints | Series A | 6.5M |
| 10/2006 | Songbird | Series A | 1M |
| 6/2014 | Navitor Pharmaceuticals | Series A | 23.5M |
| 5/2014 | Rodin Therapeutics | Series A | 12.9M |
| 10/2005 | Newron Pharmaceuticals | Series B | 8.4M |
| 4/2004 | Archemix | Series B | 50M |
| 1/2009 | Valore | Series C | 6M |
| 10/2006 | 3V Transaction Services | Series A | 25.5M |
| 4/2014 | Threat Stack | Series A | 2.7M |
| 7/2000 | Alltrue | Series A | 8M |
| 1/2006 | Liquid Machines | Series B | 5M |
| 8/2000 | Phase Forward | Venture Round | 25M |
| 10/2011 | Arteaus Therapeutics | Venture Round | 18M |
| 5/2014 | Lysosomal Therapeutics | Seed Round | 4.8M |
| 10/2008 | InfaCare Pharmaceutical | Series B | 28M |
| 9/2002 | Aureon Laboratories | Series A | 15M |
| 6/2000 | Get Connected Inc | Series A | 12M |
| 12/2005 | Resolvyx Pharmaceuticals | Series A | 17M |
| 6/2013 | Rodin Therapeutics | Seed Round | - |
| 8/2012 | Sqrrl Data, Inc. | Seed Round | 2M |
| 11/2006 | Stockholm Interactive | Series A | 3M |
| 1/2016 | Rodin Therapeutics | Series B | 17.3M |
| 10/2004 | Livevault | Series C | 5M |
| 5/2014 | Vhoto | Seed Round | 2.4M |
| 12/2002 | Liquid Machines | Series A | 4.6M |
| 10/2014 | Cogent Biosciences | Series A | 12.3M |
| 12/2012 | Gocella | Seed Round | 625k |
| 4/2013 | Rocketmiles | Seed Round | 2M |
| 7/2010 | Integral Ad Science | Series B | 0 |
| 7/2006 | BlueShift Technologies | Series B | 12M |
| 10/2013 | Sqrrl Data, Inc. | Series A | 5.2M |
| 7/2006 | Isilon Systems | Series E | 10M |
| 10/2005 | KDS | Series A | 13.3M |
| 12/2009 | Icera | Private Equity Round | 60M |
| 7/2013 | Signaldataco | Series A | 2M |
| 8/2014 | Drop Messages | Seed Round | 1.3M |
| 7/2012 | Annovation BioPharma | Venture Round | 2M |
| 7/2007 | Ubiquisys | Series B | 25M |
| 6/2002 | Sandbridge Technologies | Series A | 14M |
| 6/2013 | Cadent Therapeutics | Series A | 6M |
| 10/2013 | Threat Stack | Seed Round | 1.2M |
| 7/2005 | Ellacoya Networks | Series D | 13.5M |
| 2/2005 | Azea Networks | Series C | 8M |
| 10/2004 | Xelerated | Venture Round | 10M |
| 6/2014 | Oyo Sportstoys | Seed Round | 3M |
| 12/2004 | Gotuit | Series B | 10M |
| 9/2012 | Ubersense | Seed Round | 1.1M |
| 7/2004 | Scali | Series C | 0 |
| 1/2018 | Korro Bio | Seed Round | - |
| 11/2000 | Systemonic | Series B | 0 |
| 3/2006 | Bluespec | Series B | 4.5M |
| 11/2006 | datango | Series A | 2.6M |
| 6/2014 | Viridian Therapeutics | Series B | 7M |
| 2/2011 | Zin.gl | Seed Round | 500k |
| 9/2000 | Viquity | Series C | 18.5M |
| 2/2003 | Icera | Series A | 10M |
| 9/2014 | CardFlight | Debt Financing | 750k |
| 4/2014 | Currencycloud | Series B | 10M |
| 4/2020 | Cadent Therapeutics | Series B | 15M |
| 7/2012 | Kinvey | Series A | 5M |
| 9/2021 | Disc Medicine | Post-IPO Equity | 0 |
| 10/2007 | CLK Design Automation | Series B | 4M |
| 12/2012 | Bicycle Therapeutics | Venture Round | 6M |
| 10/2013 | CardFlight | Seed Round | 1.6M |
| 5/2018 | Accent Therapeutics | Series A | 40M |
| 10/2012 | The Tap Lab | Seed Round | 1M |
| 2/2015 | Inmoji | Seed Round | 1M |
| 5/2001 | Netonomy | Series C | 15M |
| 9/2021 | Disc Medicine | Series B | 90M |
| 6/2003 | Prestwick Pharmaceuticals | Series A | 15M |
| 11/2011 | Objective Logistics | Seed Round | 1.5M |
| 4/2013 | Fashion Project | Seed Round | 1.8M |
| 4/2017 | SimpleReach | Series B | 0 |
| 6/2005 | Pixtronix | Series A | 3M |
| 8/2014 | DraftKings | Series C | 41M |
| 8/2022 | Disc Medicine | Post-IPO Equity | 0 |
| 6/2013 | CustomMade | Series B | 0 |
| 8/2020 | Aerovate Therapeutics | Series A | 72.6M |
| 10/2007 | Carbon Black | Series C | 10M |
| 4/2012 | Ark | Seed Round | 4.2M |
| 2/2002 | Livevault | Venture Round | 8M |
| 6/2012 | Chill, Inc. | Series A | 8M |
| 8/2007 | Prestwick Pharmaceuticals | Venture Round | 20M |
| 9/2011 | Chill | Angel Round | 1.5M |
| 7/2004 | Kalido | Series B | 10M |
| 1/2020 | Quench Bio | Series A | 50M |
| 2/2011 | InsightSquared | Seed Round | 1M |
| 2/2021 | Day One Biopharmaceuticals | Series B | 130M |
| 5/2005 | Isilon Systems | Series D | 20M |
| 11/2007 | Kalido | Series D | 10M |
| 5/2012 | InsightSquared | Series A | 4.5M |
| 3/2000 | Spotfire | Series C | 15M |
| 7/2014 | SimpleReach | Series A | 0 |
| 12/2008 | Solyndra | Series E | 220M |
| 1/2020 | Generation Bio | Series C | 110M |
| 8/2007 | Adnexus | Series C | 15.5M |
| 3/2013 | clypd | Series A | 3.2M |
| 6/2007 | Seatwave | Series B | 8M |
| 9/2012 | DisplayLink | Venture Round | 10.4M |
| 11/2012 | Jeeng | Series A | 10M |
| 11/2014 | Paracosm | Seed Round | 3.3M |
| 3/2007 | Advanced Electron Beams | Series B | 17.5M |
| 8/2013 | Sqwiggle | Seed | 1.1M |
| 6/2014 | WHOOP | Series A | 6M |
| 5/2014 | Earnest | Seed Round | 4.3M |
| 5/2011 | COLOURlovers | Venture Round | 1M |
| 3/2014 | Valore | Series E | 0 |
| 5/2013 | Valore | Series D | 0 |
| 4/2013 | Lagoa | Seed Round | 1.6M |
| 10/2020 | Scorpion Therapeutics | Series A | 108M |
| 10/2013 | F-Star Therapeutics | Series A | 0 |
| 2/2016 | Synlogic | Series B | 40M |
| 12/2020 | Vigil Neuroscience | Series A | 50M |
| 1/2017 | Translate Bio | Series C | 51M |
| 10/2006 | Prestwick Pharmaceuticals | Series C | 60M |
| 3/2010 | Larimar Therapeutics | Series B | 28M |
| 12/2012 | Larimar Therapeutics | Series D | 21M |
| 1/2014 | ZappRx | Seed Round | 1M |
| 10/2000 | Inspired Capital plc | Series A | 0 |
| 1/2010 | F-Star Therapeutics | Series A | 11.5M |
| 5/1998 | Actelion Pharmaceuticals | Venture Round | 12M |
| 10/2021 | Rectify Pharmaceuticals | Series A | 0 |
| 10/2009 | Bicycle Therapeutics | Seed Round | - |
| 10/2014 | Quartet Medicine | Series A | 17M |
| 10/2014 | Bicycle Therapeutics | Series A | 32M |
| 11/2019 | Arkuda Therapeutics | Series A | 44M |
| 6/2018 | Nimbus Therapeutics | Series B | 65M |
| 6/2017 | Bicycle Therapeutics | Series B | 52M |
| 9/2014 | Surface Oncology | Seed Round | - |
| 10/2014 | Raze Therapeutics | Series A | 24M |
| 3/2013 | CoStim Pharmaceuticals | Series A | 22M |
| 6/2006 | Adnexus | Series B | 27M |
| 11/2007 | DisplayLink | Series C | 24M |
| 4/2013 | Bluetrain.io | Seed Round | 1.5M |
| 3/2003 | Adnexus | Series A | 13M |
| 3/2006 | Veracode | Series A | 7.5M |
| 12/2015 | Navitor Pharmaceuticals | Series B | 33M |
| 1/2007 | Veracode | Series B | 19.5M |
| 3/2004 | Momenta Pharmaceuticals | Series C | 20.5M |
| 1/2022 | Korro Bio | Series B | 0 |
| 4/2010 | Aureon Laboratories | Series D | 7M |
| 7/2014 | Plastiq | Series B | 10M |
| 8/2007 | Avila Therapeutics | Series A | - |
| 10/2012 | docTrackr | Seed Round | 2M |
| 5/2010 | Icera | Private Equity Round | 45M |
| 9/2021 | Obsidian Therapeutics | Series B | 0 |
| 12/2021 | Curie Therapeutics | Series A | 75M |
| 6/2000 | LexiQuest | Series C | 25M |
| 10/2002 | Wavesmith Networks | Series C | 0 |
| 3/1998 | FutureTense | Venture Round | 5.3M |
| 9/2005 | Realeyes 3D | Series B | 9.3M |
| 3/2020 | Affinia Therapeutics | Series A | 0 |
| 5/2021 | Affinia Therapeutics | Series B | 0 |
| 2/2014 | Egalet | Post-IPO Equity | - |
| 10/2012 | Secret Escapes | Series B | 12.9M |
| 7/2007 | VirtualLogix | Series B | 16M |
| 1/2014 | Rocketmiles | Series A | 6.5M |
| 4/2008 | Stromedix | Series B | 25M |
| 5/2017 | Magenta Therapeutics | Series B | 0 |
| 7/2013 | WHOOP | Seed Round | 3M |
| 7/2000 | eRoom Technology | Private Equity Round | 21M |
| 1/2012 | GrabCAD | Series A | 4M |
| 3/2020 | Xilio Therapeutics | Series B | 100.5M |
| 6/2011 | EDITED | Seed Round | 1.6M |
| 9/2011 | DisplayLink | Series D | 15M |
| 12/2007 | Lilliputian Systems | Series C | 20M |
| 7/2012 | Carbon Black | Series D | 34.5M |
| 7/2002 | Isilon Systems | Series B | 15M |
| 3/2004 | Isilon Systems | Series C | 15.5M |
| 8/2005 | Tribotek | Venture Round | 13M |
| 12/2021 | K36 Therapeutics | Series A | 30M |
| 1/2021 | Scorpion Therapeutics | Series B | 162M |
| 3/2013 | Discoverly | Seed Round | 750k |
| 9/2014 | Wedding Spot | Series A | 3M |
| 6/2008 | NTRglobal | Series C | 0 |
| 12/2009 | DisplayLink | Series C | 8M |
| 7/2015 | Secret Escapes | Series C | 60M |
| 10/2012 | GrabCAD | Series B | 8.2M |
| 11/2000 | Artel Video Systems | Series B | 10.5M |
| 9/2013 | AngelList Talent | Series B | 24M |
| 3/2023 | Chroma Medicine | Series B | 0 |
| 11/2021 | HotSpot Therapeutics | Series C | 0 |
| 1/2000 | NaviNet | Venture Round | 20.2M |
| 7/2011 | Abine | Series A | 6.5M |
| 8/2000 | cassiopeia | Venture Round | - |
| 4/2022 | Sionna Therapeutics | Series B | 0 |
| 2/2016 | Avrobio | Seed Round | - |
| 3/2015 | Nimbus Therapeutics | Series B | 43M |
| 7/2014 | Robin | Seed Round | 2.1M |
| 8/2020 | Dyne Therapeutics | Series B | 115M |
| 1/2007 | F-Star Therapeutics | Seed Round | 2M |
| 11/2013 | clypd | Series A | 7.3M |
| 1/2018 | Harbour Biomed | Series A | - |
| 2/2005 | SAFE ID Solutions | Series A | 9.1M |
| 2/2022 | Arkuda Therapeutics | Series B | 0 |
| 8/2005 | Zinwave UK | Series A | 7.6M |
| 1/2019 | Triplet Therapeutics | Seed Round | 10M |
| 4/2004 | Performix Technologies | Series C | 10M |
| 4/2000 | SkillsVillage | Series B | 0 |
| 4/2004 | Supplyworks | Series E | - |
| 9/2014 | Q4 | Venture Round | 4.6M |
| 3/2007 | Marathon Technologies | Series B | 12M |
| 9/2006 | Larimar Therapeutics | Series A | 5.2M |
| 1/2008 | Zoopla | Seed Round | 2.9M |
| 8/2005 | Supplyworks | Series F | - |
| 4/2003 | Supplyworks | Venture Round | 3M |
| 6/2003 | Orthogon Systems | Venture Round | 7M |
| 9/2006 | Ubiquisys | Series A | 12M |
| 6/2016 | IFM Therapeutics | Series A | 27M |
| 9/2010 | Ubiquisys | Venture Round | 0 |
| 12/2002 | Renovo | Series B | 33M |
| 8/2012 | Ubiquisys | Venture Round | 19M |
| 7/2010 | Ubiquisys | Venture Round | 9M |
| 8/2007 | Dailymotion | Series B | 34M |
| 3/2000 | Variagenics | Funding Round | 19M |
| 12/2013 | Secret Escapes | Venture Round | - |
| 5/2008 | Viridian Therapeutics | Series A | 8M |
| 6/2001 | picoChip | Series A | 7M |
| 9/2008 | Lumavita | Series A | 16.2M |
| 1/2000 | Systemonic | Series A | 5M |
| 9/1999 | GoCargo | Series A | - |
| 12/2017 | Obsidian Therapeutics | Series A | 0 |
| 7/2012 | OwnerIQ | Series E | 0 |
| 9/2016 | Delinia | Series A | 35M |
| 5/2017 | Synlogic | Series C | 42M |
| 2/2008 | Liquid Machines | Series D | 10M |
| 1/2013 | EnglishCentral | Venture Round | 2M |
| 6/2012 | Psykosoft | Seed Round | 500k |
| 6/2011 | OwnerIQ | Series D | 0 |
| 12/2009 | OwnerIQ | Series C | 5.8M |
| 10/2001 | Xelerated | Series B | 12M |
| 7/2020 | Cogent Biosciences | Post-IPO Equity | 104.4M |
| 1/1994 | ArQule | Seed Round | - |
| 1/1992 | MorphoSys | Seed Round | - |
| 1/2012 | Teads.tv | Series A | 0 |
| 10/2013 | Nextly | Seed Round | 1.8M |
| 11/2003 | Corizon | Venture Round | 3M |
| 6/2008 | OwnerIQ | Series B | 6M |
| 12/2004 | Novexel | Series A | 53.6M |
| 2/2008 | Seatwave | Series C | 25M |
| 3/2013 | 3V Transaction Services | Venture Round | 25.5M |
| 5/2003 | Momenta Pharmaceuticals | Series B | 19M |
| 12/2012 | Plizy | Series A | 4M |
| 10/2013 | Fancred | Seed | 1.5M |
| 1/1998 | DeCODE Genetics | Seed Round | - |
| 6/2003 | Sandbridge Technologies | Series B | 19.5M |
| 4/2009 | Lilliputian Systems | Series D | 28M |
| 1/2008 | NovaMed Pharmaceuticals | Series B | 13.8M |
| 7/2003 | Kalido | Series A | 18M |
| 8/2009 | Advanced Electron Beams | Series C | 0 |
| 9/2003 | Phyworks | Series B | 13.3M |
| 2/2000 | AP Engines | Series A | 10M |
| 6/2003 | Ellacoya Networks | Venture Round | 14M |
| 5/1998 | E Ink | Venture Round | 15.8M |
| 1/2000 | Crucell Holland BV | Seed Round | - |
| 12/2012 | Grockit | Unattributed | 20M |
| 10/2011 | Grockit | Series D | 7M |
| 1/2009 | CloudSwitch | Series A | 7.4M |
| 5/2006 | Seatwave | Series A | 3M |
| 2/2000 | eSupportNow | Venture Round | 11.5M |
| 7/2005 | Vitae Pharmaceuticals | Series C | 15M |
| 4/2012 | Integral Ad Science | Series C | 0 |
| 2/2013 | HStreaming | Seed Round | 1M |
| 8/2017 | Indalo Therapeutics | Venture Round | 9M |
| 12/1999 | eGroups | Venture Round | 42M |
| 4/2022 | Be Biopharma | Series B | 0 |
| 4/2000 | Micromet | Seed Round | 10.5M |
| 9/1999 | Mixad | Seed Round | 529.7k |
| 7/1999 | Exelixis | Seed Round | 4M |
| 7/2012 | Arteaus Therapeutics | Venture Round | 12M |
| 3/2010 | dataxu | Series B | 11M |
| 3/2017 | Spero Therapeutics | Series C | 51.7M |
| 1/2002 | Hyperwave | Venture Round | 18M |
| 12/2019 | Triplet Therapeutics | Series A | 49M |
| 1/2012 | VideoIQ | Series C | 3.5M |
| 1/2001 | Fireclick | Series C | 13.5M |
| 1/2014 | SecurityScorecard | Seed Round | 2.2M |
| 5/2010 | Grockit | Series C | 7M |
| 2/2002 | Sequence Design | Venture Round | 20M |
| 8/2014 | DataRobot | Series A | 21M |
| 10/2003 | Anadigm | Series C | 15M |
| 1/2008 | ShoZu | Series C | 12M |
| 9/2018 | Xilio Therapeutics | Series A | 30M |
| 2/2014 | dataxu | Series E | 10M |
| 2/2000 | CitiKey | Venture Round | 11.5M |
| 1/2002 | Artel Video Systems | Series D | 4.4M |
| 4/2007 | Sirion Therapeutics | Series B | 45M |
| 4/2012 | Veracode | Series E | 30M |
| 9/2014 | Veracode | Series F | 40M |
| 4/2011 | Carbon Black | Equity | 12.5M |
| 6/2006 | Starbak | Venture Round | 2.5M |
| 11/2007 | Vitae Pharmaceuticals | Series D | 15M |
| 4/2020 | Accent Therapeutics | Series B | 0 |
| 2/2015 | Viridian Therapeutics | Series B | 0 |
| 12/2011 | Keas | Series A | 7M |
| 4/2001 | Mspect | Series A | 9M |
| 12/2006 | Valore | Series B | 7.5M |
| 8/2000 | Wavesmith Networks | Series A | 11.5M |
| 2/2012 | On-Q-ity | Series B | 5M |
| 6/2013 | Boatbound | Seed Round | 1M |
| 5/2005 | Netonomy | Series E | 4.4M |
| 10/2011 | PowerInbox, Inc. | Seed Round | 0 |
| 3/2007 | Stromedix | Series A | 1M |
| 4/2014 | Preact, Inc. | Series A | 4.6M |
| 10/2017 | Gemini Therapeutics | Series A | 42.5M |
| 11/2010 | EnglishCentral | Private Equity Round | 7.1M |
| 12/2013 | Lagoa | Series A | 5.3M |
| 7/2013 | Objective Logistics | Series A | 0 |
| 5/2002 | eMusicLive | Series C | 1.5M |
| 9/2014 | Bridj | Seed | 4M |
| 7/2005 | DisplayLink | Series A | 8M |
| 5/2012 | BuysideFX | Seed Round | - |
| 12/2014 | Padlock Therapeutics | Series A | 23M |
| 11/2021 | Matchpoint Therapeutics | Seed | 30M |
| 7/2003 | Xelerated Holdings | Venture Round | 12.5M |
| 7/2008 | VideoIQ | Series B | 10M |
| 4/2007 | VideoIQ | Series A | 8M |
| 10/2014 | PillPack | Series B | 0 |
| 7/2003 | Xelerated | Venture Round | 12.5M |
| 11/2009 | picoChip | Series E | 0 |
| 6/2007 | picoChip | Series D | 0 |
| 11/2012 | Skillz | Seed Round | 500k |
| 10/2005 | Nitec Pharma AG | Series A | 10M |
| 7/2012 | Objective Logistics | Debt Financing | 1.4M |
| 6/2005 | picoChip | Series C | 20.5M |
| 8/2007 | ShoZu | Venture Round | 12M |
| 4/2001 | Isilon Systems | Series A | 8.4M |
| 9/2005 | Carbon Black | Series A | 6M |
| 4/2005 | Xelerated | Series C | 17M |
| 1/2004 | VirtualLogix | Series A | 12M |
| 11/2020 | F-Star Therapeutics | Post-IPO Equity | 0 |
| 8/2014 | Fancred | Equity | 3M |
| 5/2020 | Day One Biopharmaceuticals | Series A | 60M |
| 5/2021 | Vedere Bio ll | Series A | 0 |
| 7/2013 | PillPack | Series A | 3.5M |
| 8/2005 | Collax | Series A | 8.4M |
| 3/2012 | Currencycloud | Series A | 4M |
| 9/2007 | Icera | Series D | 40M |
| 11/2006 | Mascoma | Series B | 30M |
| 9/2011 | VideoIQ | Series C | 7.5M |
| 10/2017 | Kymera Therapeutics | Series A | 30M |
| 3/2006 | ExtendMedia | Series A | 11M |
| 8/2015 | Mobee | Series A | 5M |
| 10/2014 | Synlogic | Series A | 5M |
| 6/2009 | CloudSwitch | Series B | 8M |
| 1/2002 | Achillion Pharmaceuticals | Venture Round | 41M |
| 10/2013 | Nutonian | Series A | 4M |
| 6/2007 | Pixtronix | Venture Round | 22M |
| 12/2011 | Unbounce | Venture Round | 850k |
| 4/2003 | Artel Video Systems | Debt Financing | 1M |
| 10/2003 | U3 Pharma | Venture Round | 16.8M |
| 9/2020 | Korro Bio | Series A | 0 |
| 11/2013 | Colingo | Seed Round | 2.4M |
| 6/2012 | Snapguide | Series A | 5M |
| 8/2011 | Hopper | Series A | 8M |
| 12/2017 | Ikena Oncology | Series A | 49M |
| 7/2014 | Synlogic | Series A | 29.4M |
| 9/1999 | Artel Video Systems | Series A | 16M |
| 10/2009 | EnglishCentral | Seed Round | 1.4M |
| 6/2007 | ARCA biopharma | Series B | 18M |
| 6/2009 | Viridian Therapeutics | Series A | 4M |
| 5/2022 | Remix Therapeutics | Series B | 0 |
| 4/2022 | Sionna Therapeutics | Series B | 0 |
| 4/2022 | Be Biopharma | Series B | 0 |
| 2/2022 | Arkuda Therapeutics | Series B | 0 |
| 1/2022 | Korro Bio | Series B | 0 |
| 12/2021 | K36 Therapeutics | Series A | 0 |
| 12/2021 | Curie Therapeutics | Series A | 0 |
| 11/2021 | HotSpot Therapeutics | Series C | 0 |
| 10/2021 | Rectify Pharmaceuticals | Series A | 0 |
| 9/2021 | Obsidian Therapeutics | Series B | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
